Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases

Explore clinical trials studying Lung Diseases. Study availability and eligibility vary by location and protocol.

893 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases trial results

Recruiting

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

NCT07407933

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Site 1001 Washington D.C., District of Columbia, United States
  • Site 1004 Louisville, Kentucky, United States
  • Site 1005 Houston, Texas, United States
  • Site 1002 Fairfax, Virginia, United States
View all 38 locations
View Trial Details
Recruiting

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

NCT07059091

Conditions
Allergies, Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), +9 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of Arizona- Tuscon Tucson, Arizona, United States
  • University of San Francisco San Francisco, California, United States
  • National Jewish Health Denver, Colorado, United States
View all 23 locations
View Trial Details
Recruiting

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

NCT07284602

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), +6 more
Locations
  • Palmtree Clinical Research Inc. Palm Spring, California, United States
  • Paradigm Clinical Research Centers LLC Redding, California, United States
  • Infinity Medical Research North Dartmouth, Massachusetts, United States
  • Clinical Research Associates of Central PA DuBois, Pennsylvania, United States
View Trial Details
Recruiting

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

NCT07333183

Conditions
Cardiovascular Diseases, Fibrosis, Hypertension, +9 more
Locations
  • Clinical Research Site Santa Barbara, California, United States
  • Clinical Research Site Torrance, California, United States
  • Clinical Research Site Kissimmee, Florida, United States
  • Clinical Research Site Chicago, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

NCT05967689

Conditions
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations, Carcinoma, Lung Diseases, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope - Duarte Duarte, California, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Comprehensive Cancer Centers of Nevada - Central Valley - Twain Las Vegas, Nevada, United States
View all 80 locations
View Trial Details

Related conditions